142 related articles for article (PubMed ID: 9472712)
1. Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen.
Shibata MA; Jorcyk CL; Devor DE; Yoshidome K; Rulong S; Resau J; Roche N; Roberts AB; Ward JM; Green JE
Carcinogenesis; 1998 Jan; 19(1):195-205. PubMed ID: 9472712
[TBL] [Abstract][Full Text] [Related]
2. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
Shibata MA; Maroulakou IG; Jorcyk CL; Gold LG; Ward JM; Green JE
Cancer Res; 1996 Jul; 56(13):2998-3003. PubMed ID: 8674054
[TBL] [Abstract][Full Text] [Related]
3. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.
Green JE; Shibata MA; Yoshidome K; Liu ML; Jorcyk C; Anver MR; Wigginton J; Wiltrout R; Shibata E; Kaczmarczyk S; Wang W; Liu ZY; Calvo A; Couldrey C
Oncogene; 2000 Feb; 19(8):1020-7. PubMed ID: 10713685
[TBL] [Abstract][Full Text] [Related]
4. Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression.
Maroulakou IG; Shibata MA; Anver M; Jorcyk CL; Liu Ml; Roche N; Roberts AB; Tsarfaty I; Reseau J; Ward J; Green JE
Oncogene; 1999 Sep; 18(39):5435-47. PubMed ID: 10498897
[TBL] [Abstract][Full Text] [Related]
5. The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.
Shibata MA; Jorcyk CL; Liu ML; Yoshidome K; Gold LG; Green JE
Toxicol Pathol; 1998; 26(1):177-82. PubMed ID: 9502400
[No Abstract] [Full Text] [Related]
6. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
[TBL] [Abstract][Full Text] [Related]
7. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
Lab Invest; 1998 Jun; 78(6):i-xv. PubMed ID: 9645768
[TBL] [Abstract][Full Text] [Related]
8. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
9. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.
Maroulakou IG; Anver M; Garrett L; Green JE
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11236-40. PubMed ID: 7972041
[TBL] [Abstract][Full Text] [Related]
10. Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors.
Zheng X; Gao JX; Zhang H; Geiger TL; Liu Y; Zheng P
J Immunol; 2002 Nov; 169(9):4761-9. PubMed ID: 12391185
[TBL] [Abstract][Full Text] [Related]
11. Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic mice.
Maroulakou IG; Shibata MA; Jorcyk CL; Chen XX; Green JE
Mol Carcinog; 1997 Oct; 20(2):168-74. PubMed ID: 9364206
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
[TBL] [Abstract][Full Text] [Related]
13. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
14. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.
Shibata MA; Liu ML; Knudson MC; Shibata E; Yoshidome K; Bandey T; Korsmeyer SJ; Green JE
EMBO J; 1999 May; 18(10):2692-701. PubMed ID: 10329616
[TBL] [Abstract][Full Text] [Related]
15. Directed expression of simian virus 40 T-antigen in transgenic mice using the epidermal growth factor gene promoter.
Pascall IC; Surani MA; Barton SC; Vaughan TJ; Brown KD
J Mol Endocrinol; 1994 Jun; 12(3):313-25. PubMed ID: 7916970
[TBL] [Abstract][Full Text] [Related]
16. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
17. Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.
Huss WJ; Gray DR; Tavakoli K; Marmillion ME; Durham LE; Johnson MA; Greenberg NM; Smith GJ
Neoplasia; 2007 Nov; 9(11):938-50. PubMed ID: 18030362
[TBL] [Abstract][Full Text] [Related]
18. Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression.
Soares CR; Shibata MA; Green JE; Jorcyk CL
Neoplasia; 2002; 4(2):112-20. PubMed ID: 11896566
[TBL] [Abstract][Full Text] [Related]
19. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
20. The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice.
Sandmöller A; Halter R; Gómez-La-Hoz E; Gröne HJ; Suske G; Paul D; Beato M
Oncogene; 1994 Oct; 9(10):2805-15. PubMed ID: 8084586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
